Sertralin

ApprovedSmall molecule

LLudwig-Maximilians - University of Munich

Sertralin is one of 56 small molecule programs targeting Depressive Disorder. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Depressive DisorderActive, not recruiting

Depressive DisorderApproved

Active, not recruiting

Competition

Competitive Landscape

93 competitors in Depressive Disorder

#DrugCompanyPhaseTrials

Bayer Aspirin

Voltaren

Ritalin

Nicorette

Estrace

Crestor

Vyvanse

Revia

Spravato

1 10

Lamictal

GGlaxo Dba Glaxosmithkline

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Post-ApprovalRecruiting

Treatment

NCT07478796

Clinical

Trials by Indication[1]

Treatment1 trial

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

Recruiting·PPoznan University of Medical Sciences·Phase 4·NCT07478796·180 enrolled

Depressive Disorder1 trial

Treatment of Mild and Subthreshold Depressive Disorders

Unknown status·LLudwig-Maximilians - University of Munich·Phase 4·NCT00226642·369 enrolled

Antidepressants1 trial

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Completed·SSykehuset Innlandet HF·Phase 4·NCT00433121·24 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Sertralin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sertralin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sertralin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ludwig-Maximilians - University of Munich company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: LLudwig-Maximilians - University of Munich

Sertralin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Treatment1 trial

Depressive Disorder1 trial

Antidepressants1 trial

References

Drug Info

Quick Facts

Related News